These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16687477)

  • 21. Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanism.
    Baucum AJ; Rau KS; Riddle EL; Hanson GR; Fleckenstein AE
    J Neurosci; 2004 Mar; 24(13):3436-43. PubMed ID: 15056723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Environmental enrichment reduces methamphetamine cue-induced reinstatement but does not alter methamphetamine reward or VMAT2 function.
    Hofford RS; Darna M; Wilmouth CE; Dwoskin LP; Bardo MT
    Behav Brain Res; 2014 Aug; 270():151-8. PubMed ID: 24821405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicity.
    Truong JG; Wilkins DG; Baudys J; Crouch DJ; Johnson-Davis KL; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1087-92. PubMed ID: 15901804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rapid oxidation and persistent decrease in the vesicular monoamine transporter 2 after methamphetamine.
    Eyerman DJ; Yamamoto BK
    J Neurochem; 2007 Nov; 103(3):1219-27. PubMed ID: 17683483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methamphetamine rapidly decreases mouse vesicular dopamine uptake: role of hyperthermia and dopamine D2 receptors.
    Ugarte YV; Rau KS; Riddle EL; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2003 Jul; 472(3):165-71. PubMed ID: 12871750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A single methamphetamine administration rapidly decreases vesicular dopamine uptake.
    Brown JM; Riddle EL; Sandoval V; Weston RK; Hanson JE; Crosby MJ; Ugarte YV; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2002 Aug; 302(2):497-501. PubMed ID: 12130707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
    Biezonski DK; Meyer JS
    J Neurochem; 2010 Feb; 112(4):951-62. PubMed ID: 20002520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetic analysis of developmental changes in vesicular monoamine transporter-2 function.
    Volz TJ; Hanson GR; Fleckenstein AE
    Synapse; 2006 Nov; 60(6):474-7. PubMed ID: 16897727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methamphetamine self-administration acutely decreases monoaminergic transporter function.
    McFadden LM; Stout KA; Vieira-Brock PL; Allen SC; Nielsen SM; Wilkins DG; Hanson GR; Fleckenstein AE
    Synapse; 2012 Mar; 66(3):240-5. PubMed ID: 22120988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine-induced dopaminergic deficits.
    Volz TJ; Hanson GR; Fleckenstein AE
    J Neurochem; 2007 May; 101(4):883-8. PubMed ID: 17250674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine.
    Lee NR; Zheng G; Leggas M; Janganati V; Nickell JR; Crooks PA; Bardo MT; Dwoskin LP
    J Pharmacol Exp Ther; 2019 Nov; 371(2):526-543. PubMed ID: 31413138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GABA, glutamate, dopamine and serotonin transporters expression on memory formation and amnesia.
    Tellez R; Gómez-Víquez L; Meneses A
    Neurobiol Learn Mem; 2012 Feb; 97(2):189-201. PubMed ID: 22183017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles.
    Volz TJ; Farnsworth SJ; King JL; Riddle EL; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2007 Nov; 323(2):738-45. PubMed ID: 17693585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis.
    Larsen KE; Fon EA; Hastings TG; Edwards RH; Sulzer D
    J Neurosci; 2002 Oct; 22(20):8951-60. PubMed ID: 12388602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of kinetically resolved vesicular dopamine uptake and efflux using rotating disk electrode voltammetry.
    Volz TJ; Hanson GR; Fleckenstein AE
    J Neurosci Methods; 2006 Jul; 155(1):109-15. PubMed ID: 16480775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic stress enhances methamphetamine-induced extracellular glutamate and excitotoxicity in the rat striatum.
    Tata DA; Yamamoto BK
    Synapse; 2008 May; 62(5):325-36. PubMed ID: 18288648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of methamphetamine on serotonin transporter activity: role of dopamine and hyperthermia.
    Haughey HM; Fleckenstein AE; Metzger RR; Hanson GR
    J Neurochem; 2000 Oct; 75(4):1608-17. PubMed ID: 10987842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of glutamate release by α7 nicotinic receptors: differential role in methamphetamine-induced damage to dopaminergic and serotonergic terminals.
    Northrop NA; Smith LP; Yamamoto BK; Eyerman DJ
    J Pharmacol Exp Ther; 2011 Mar; 336(3):900-7. PubMed ID: 21159748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms underlying methamphetamine-induced dopamine transporter complex formation.
    Hadlock GC; Baucum AJ; King JL; Horner KA; Cook GA; Gibb JW; Wilkins DG; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2009 Apr; 329(1):169-74. PubMed ID: 19141713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of methamphetamine on Na(+)/Cl(-)-dependent transporters.
    Haughey HM; Brown JM; Wilkins DG; Hanson GR; Fleckenstein AE
    Brain Res; 2000 Apr; 863(1-2):59-65. PubMed ID: 10773193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.